Lv51
1504 积分 2026-06-02 加入
煤系高岭土氯化焙烧除铁增白工艺及原理研究 Research on the process and principle of iron removal and whitening by chlorination roasting of coal-series kaolin
2天前
已完结
Removal, conversion and utilization technologies of alkali components in bayer red mud
13天前
已完结
高硅低品位铝土矿脱硅技术研究进展与展望
1个月前
已完结
高岭土/铜复合材料的制备及抗病菌涂料应用性能研究 Preparation of Kaolin-Copper Composites and Their Application in Antimicrobial Coatings
1个月前
已完结
卧式砂磨机对高岭土超细加工效果的研究 Research on the Effect on Ultra-fine Sample Processing of Kaolin Clay by Horizontal Sand Mill
1个月前
已完结
高岭土除铁增白研究 Research on Iron Removal and Whitening of Kaolin
1个月前
已完结
高档造纸面涂级高岭土原料优选与评价技术研究 Research on the Optimization and Evaluation Technology of High-Grade Kaolin Raw Materials for Paper Coating
1个月前
已完结
高岭土在生产橡胶管填料中的应用分析 Application of Kaolin in the Production of Rubber Tube Filler
2个月前
已完结
国外某高岭土矿床矿石深加工技术研究 Research on Advanced Processing Technologies of a Certain Kaolin Deposit Abroad
2个月前
已完结
多力场协同优化制备高档造纸涂布高岭土工艺研究 Research on the Preparation Process of High-Grade Paper Coating Kaolin by Multi-Field Synergistic Optimization
2个月前
已完结
Safety, Biodistribution, and Dosimetry of FAP and Integrin α v β 3 Dual-Targeting Radioligand 177 Lu-DOTA-FAPI-RGD: Preclinical Validation and First-in-Human Study in Patients with Advanced Adenocarcinomas
4天前
已采纳
Safety, Biodistribution, and Dosimetry of FAP and Integrin α v β 3 Dual-Targeting Radioligand 177 Lu-DOTA-FAPI-RGD: Preclinical Validation and First-in-Human Study in Patients with Advanced Adenocarcinomas
4天前
已采纳
Safety, Biodistribution, and Dosimetry of FAP and Integrin αvβ3 Dual-Targeting Radioligand 177Lu-DOTA-FAPI-RGD: Preclinical Validation and First-in-Human Study in Patients with Advanced Adenocarcinomas
4天前
已采纳
Safety, Biodistribution, and Dosimetry of FAP and Integrin α v β 3 Dual-Targeting Radioligand 177 Lu-DOTA-FAPI-RGD: Preclinical Validation and First-in-Human Study in Patients with Advanced Adenocarcinomas
4天前
已采纳
Safety, Biodistribution, and Dosimetry of FAP and Integrin α v β 3 Dual-Targeting Radioligand 177 Lu-DOTA-FAPI-RGD: Preclinical Validation and First-in-Human Study in Patients with Advanced Adenocarcinomas
4天前
已采纳
Safety, Biodistribution, and Dosimetry of FAP and Integrin α v β 3 Dual-Targeting Radioligand 177 Lu-DOTA-FAPI-RGD: Preclinical Validation and First-in-Human Study in Patients with Advanced Adenocarcinomas
4天前
已采纳
Safety, Biodistribution, and Dosimetry of FAP and Integrin α v β 3 Dual-Targeting Radioligand 177 Lu-DOTA-FAPI-RGD: Preclinical Validation and First-in-Human Study in Patients with Advanced Adenocarcinomas
4天前
已采纳
Safety, Biodistribution, and Dosimetry of FAP and Integrin α v β 3 Dual-Targeting Radioligand 177 Lu-DOTA-FAPI-RGD: Preclinical Validation and First-in-Human Study in Patients with Advanced Adenocarcinomas
4天前
已采纳
Safety, Biodistribution, and Dosimetry of FAP and Integrin α v β 3 Dual-Targeting Radioligand 177 Lu-DOTA-FAPI-RGD: Preclinical Validation and First-in-Human Study in Patients with Advanced Adenocarcinomas
4天前
已采纳
CXCR4-Targeted Molecular Imaging in Hematology and Oncology
4天前
已采纳
皖公网安备34019202002308
